These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11327289)

  • 1. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study.
    Rodríguez-Pereira C; Suárez-Peñaranda JM; Vázquez-Salvado M; Sobrido MJ; Abraldes M; Barros F; Forteza J
    J Neurosurg Sci; 2000 Dec; 44(4):203-9; discussion 209-10. PubMed ID: 11327289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
    Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
    Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas.
    Onda K; Davis RL; Shibuya M; Wilson CB; Hoshino T
    Cancer; 1994 Oct; 74(7):1921-6. PubMed ID: 7521787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.
    Mastronardi L; Guiducci A; Puzzilli F; Ruggeri A
    J Neurosurg Sci; 1999 Dec; 43(4):263-70. PubMed ID: 10864388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
    Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
    Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children.
    Czech T; Slavc I; Aichholzer M; Haberler C; Dietrich W; Dieckmann K; Koos W; Budka H
    J Neurooncol; 1999 Apr; 42(2):143-50. PubMed ID: 10421072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters.
    McKeever PE; Ross DA; Strawderman MS; Brunberg JA; Greenberg HS; Junck L
    J Neuropathol Exp Neurol; 1997 Jul; 56(7):798-805. PubMed ID: 9210876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative potential of malignant glioma cells before and after interstitial brachytherapy.
    Kunishio K; Matsumoto K; Higashi H; Adachi H; Tamiya T; Furuta T; Ohmoto T
    Neurol Med Chir (Tokyo); 1999 May; 39(5):341-9. PubMed ID: 10481436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
    Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
    J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas.
    Hsu DW; Louis DN; Efird JT; Hedley-Whyte ET
    J Neuropathol Exp Neurol; 1997 Aug; 56(8):857-65. PubMed ID: 9258255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors.
    Grzybicki DM; Liu Y; Moore SA; Brown HG; Silverman JF; D'Amico F; Raab SS
    Cancer; 2001 Nov; 92(10):2720-6. PubMed ID: 11745208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
    Veronese SM; Maisano C; Scibilia J
    Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 expression in gliomas.
    Cavalla P; Dutto A; Piva R; Richiardi P; Grosso R; Schiffer D
    Acta Neuropathol; 1998 Feb; 95(2):131-5. PubMed ID: 9498046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical picture and surgical prospects of rapidly growing gliomas].
    Walter W; Schettler G; Müller W
    Dtsch Z Nervenheilkd; 1969; 196(1):1-19. PubMed ID: 4307961
    [No Abstract]   [Full Text] [Related]  

  • 18. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.
    Coons SW; Johnson PC; Pearl DK
    Neurosurgery; 1997 Oct; 41(4):878-84; discussion 884-5. PubMed ID: 9316050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
    Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
    J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.